Big Pharma kills signature drug that was at the center of $5.8 billion South S.F. deal
August 29, 2019 at 17:18 PM EDT
AbbVie hoped for big things from Stemcentrx. It got a $5.1 billion write off and the layoff of nearly 200 employees.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.